Pancreatic Cancer Cure Foundation is located in Quakertown, PA. The organization was established in 2018. According to its NTEE Classification (H11) the organization is classified as: Single Organization Support, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Pancreatic Cancer Cure Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 09/2021, Pancreatic Cancer Cure Foundation generated $77.3k in total revenue. This organization has experienced exceptional growth, as over the past 5 years, it has increased revenue by an average of 21.7% each year . All expenses for the organization totaled $78.3k during the year ending 09/2021. While expenses have increased by 25.0% per year over the past 5 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
PANCREATIC CANCER CURE FOUNDATION'S MISSION IS TO RAISE MONEY AND DISTRIBUTE FUNDING PRIMARILY TOWARDS PANCREATIC CANCER RESEARCH AND COMPASSIONATE CARE INITIATIVES, AND, TO A LESSER EXTENT, AWARENESS AND ADVOCACY EFFORTS
Describe the Organization's Program Activity:
Part 3 - Line 4a
FUNDING PROVIDED TO THE PANCREAS, BILIARY, & RELATED CANCER CENTER AT SIDNEY KIMMEL CANCER CENTER AT JEFFERSON UNIVERSITY, AN NCI-DESIGNATED FACILITY. FUNDING SUPPORTS RESEARCH TO IMPROVE EARLY DETECTION OF PANCREATIC CANCER AND DEVELOP MORE EFFECTIVE SCREENING PROCEDURES. THIS FACILITY IS LEADING INVESTIGATIONS INTO GENETIC, ENVIRONMENTAL, AND LIFESTYLE LINKS TO PANCREATIC AND RELATED CANCERS, INCLUDING NOVEL APPROACHES TO INDIVIDUALIZED THERAPY BASED ON MOLECULAR GENETIC FEATURES OF TUMORS.
FUNDING WAS PROVIDED TO ST. LUKE'S CANCER CENTER FOR "COMPASSIONATE CARE" DISTRIBUTION TO FINANCIALLY COMPROMISED PANCREATIC CANCER PATIENTS TO COVER COSTS SUCH AS TRANSPORTATION, UTILITIES, ETC.
FUNDING WAS PROVIDED TO FOX CHASE INSTITUTE FOR CANCER RESEARCH TO ADVANCE RESEARCH BEING CONDUCTED BY THE CUIKERMAN LAB/MARVIN & CONCETTA GREENBURG PANCREATIC CANCER INSTITUTE.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Anthony Cygan Vice President | OfficerTrustee | 10 | $0 |
David Cygan Secretary | OfficerTrustee | 5 | $0 |
Stephen Cygan President | OfficerTrustee | 7 | $0 |
Jane Cygan Treasurer | OfficerTrustee | 10 | $0 |
Michael Cygan Director | Trustee | 5 | $0 |
Nathan Cygan Director | Trustee | 3 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $42,599 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $29,725 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $72,324 |
Total Program Service Revenue | $0 |
Investment income | $37 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $4,927 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $77,288 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $70,000 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $0 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $0 |
Payroll taxes | $0 |
Fees for services: Management | $0 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $1,385 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $0 |
Advertising and promotion | $0 |
Office expenses | $228 |
Information technology | $5,657 |
Royalties | $0 |
Occupancy | $0 |
Travel | $0 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $890 |
All other expenses | $100 |
Total functional expenses | $78,260 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $0 |
Savings and temporary cash investments | $8,943 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $8,943 |
Accounts payable and accrued expenses | $0 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $0 |
Net assets without donor restrictions | $8,943 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $8,943 |
Over the last fiscal year, Pancreatic Cancer Cure Foundation has awarded $70,000 in support to 3 organizations.
Grant Recipient | Amount |
---|---|
Philadelphia, PA PURPOSE: FUNDING PROVIDED TO THE PANCREAS, BILIARY, & RELATED CANCER CENTER AT SIDNEY KIMMEL CANCER CENTER AT JEFFERSON UNIVERSITY, AN NCI-DESIGNATED FACILITY. FUNDING SUPPORTS RESEARCH TO IMPROVE EARLY DETECTION OF PANCREATIC CANCER AND DEVELOP MORE EFFECTIVE SCREENING PROCEDURES. THIS FACILITY IS LEADING INVESTIGATIONS INTO GENETIC, ENVIRONMENTAL, AND LIFESTYLE LINKS TO PANCREATIC AND RELATED CANCERS, INCLUDING NOVEL APPROACHES TO INDIVIDUALIZED THERAPY BASED ON MOLECULAR GENETIC FEATURES OF TUMORS. | $36,500 |
Philadelphia, PA PURPOSE: FUNDING WAS PROVIDED TO FOX CHASE INSTITUTE FOR CANCER RESEARCH TO ADVANCE RESEARCH BEING CONDUCTED BY THE CUIKERMAN LAB/MARVIN & CONCETTA GREENBURG PANCREATIC CANCER INSTITUTE | $28,500 |
Allentown, PA PURPOSE: FUNDING WAS PROVIDED TO ST. LUKE'S CANCER CENTER FOR "COMPASSIONATE CARE" DISTRIBUTION TO FINANCIALLY COMPROMISED PANCREATIC CANCER PATIENTS TO COVER COSTS SUCH AS TRANSPORTATION, UTILITIES, ETC. | $5,000 |
Over the last fiscal year, we have identified 2 grants that Pancreatic Cancer Cure Foundation has recieved totaling $17,108.
Awarding Organization | Amount |
---|---|
Network For Good Inc Washington, DC PURPOSE: UNRESTRICTED | $16,483 |
Amazonsmile Foundation Seattle, WA PURPOSE: GENERAL SUPPORT | $625 |
Organization Name | Assets | Revenue |
---|---|---|
New Jersey Health Foundation Inc Princeton, NJ | $176,302,881 | $3,140,034 |
Research To Prevent Blindness Endowment Fund Inc New York, NY | $317,713,049 | $28,546,765 |
Ats Foundation Inc New York, NY | $0 | $224,022 |
Foundation For Advancement Of Intl Medical Education And Research Philadelphia, PA | $73,208,748 | $9,951,039 |
Nccn Foundation Plymouth Meeting, PA | $7,730,910 | $3,697,738 |
Cincinnati Sight Restoration Foundation Inc Cincinnati, OH | $11,696,354 | $3,183,062 |
Foundation Fighting Blindness Retinal Degeneration Fund Columbia, MD | $45,350,093 | $15,424,974 |
The Arvo Foundation For Eye Research Inc Rockville, MD | $8,550,005 | $1,963,913 |
Cds Wolf Foundation Inc Webster, NY | $18,173,557 | $6,502,648 |
Parkinson Alliance Inc Kingston, NJ | $464,272 | $616,177 |
Margaret M Dyson Tr Uw Fbo Margaret M Dyson Vision Research Institute Poughkeepsie, NY | $4,372,343 | $800,997 |
Simons Fund Conshohocken, PA | $473,099 | $317,439 |